Versant Venture Capital VI, L.P., 10% Owner at Black Diamond Therapeutics, Inc. (BDTX), sold 719,838 shares at $34.39 ($991K) on 2020-11-12, disclosed to the SEC on 2020-11-13.
Scheduled sale ($991k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 690,814 | $0 | 0.0% |
| 2 | $33.48 | 3,976 | $133K | 13.4% |
| 3 | $33.48 | 3,976 | $133K | 13.4% |
| 4 | $33.48 | 524 | $18K | 1.8% |
| 5 | $34.39 | 9,450 | $325K | 32.8% |
| 6 | $34.39 | 1,248 |
| $43K |
| 4.3% |
| 7 | $34.39 | 9,450 | $325K | 32.8% |
| 8 | $35.15 | 47 | $2K | 0.2% |
| 9 | $35.15 | 353 | $12K | 1.3% |
| Total | $1.38 avg | 719,838 | $991K | 100% |
| Filing → |
| GLUE | SELL | 2024-10-30 | $2.8M | — | Filing → |
| GLUE | SELL | 2024-09-24 | $14.8M | — | Filing → |
| TPST | SELL | 2024-08-12 | $1.4M | — | Filing → |